Skip to main content
Full access
LETTER
Published Online: 1 October 2009

Acute Depression and Suicidal Attempt Following Lowering the Frequency of Deep Brain Stimulation

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Deep brain stimulation (DBS) is a neurosurgical intervention that enables deep brain structures to be stimulated electrically by an implanted pacemaker. 1 The method was initially developed for movement disorders in several target areas such as the thalamus, pallidum, and subthalamic nucleus. 2 It has now also been extended to other neuropsychiatric conditions and has shown some promising results in patients suffering from profound depression. 3
In depression, dysfunction of the limbic-cortico-striatal-pallidal-thalamic pathways has been proposed. 46 Although the exact mechanism of action of DBS remains elusive, stimulation of selected areas implicated in mood regulation may have therapeutic potential or lead to adverse consequences due to modulation of circuits related to depression. 5

Case Report

We report a case of a 66-year-old male who was diagnosed with Parkinson’s disease 20 years ago and was implanted with a subthalamic deep brain stimulation treatment system bilaterally for the last 8 years. He continued taking oral Parkinson’s disease medication. Subsequently, his dyskinesia and movements markedly improved. There were no psychiatric adverse events experienced following DBS implantation. Four years later, he developed a major depressive episode after his retirement and responded well to an adequate trial of bupropion. He did not report prior history of suicidal thoughts or attempts and followed up regularly with a psychiatrist.
Reportedly, for the last 5 years his neurologist had been changing the frequency of the brain stimulation through the implanted devices to negate the patient’s changing dyskinetic symptoms and disease progression. The frequency of the stimulation was lowered from 185 Hz to 60 Hz. Within 24 hours of lowering the frequency, the patient developed acute depression and made a serious suicide attempt by overdosing on sleeping pills. He was admitted to an intensive care unit and transferred to a psychiatric facility. His neurologist reportedly increased the frequency while the patient was in the hospital, and accordingly, his depressive feelings improved considerably over the next few days with complete remission of his suicidal thoughts.

Discussion

Several case reports have been published showing the potential of deep brain stimulation in the treatment of depression. 7 Our case demonstrates the risk of suicide when lowering the frequency of the stimulation. Patients undergoing an adjustment to the stimulation parameters according to their changing motor symptoms should be prescreened and assessed thoroughly for suicide risk prior to the changes. 7 Additionally, patients should be monitored closely for suicidal behavior after the changes. 7 Patients at high risk for suicide should be excluded from deep brain stimulation surgery. 8

References

1.
Pereira EA, Green AL, Nandi D, et al: Deep brain stimulation: indications and evidence. Expert Rev Med Devices 2007; 4:591–603
2.
Benabid AL: What the future holds for deep brain stimulation. Expert Rev Med Devices 2007; 4:895–903
3.
Schlaepfer TE, Cohen MX, Frick C, et al: Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33:368–377
4.
Kopell BH, Greenberg BD: Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci Biobehav Rev 2008; 32:408–422
5.
Kosel M, Sturm V, Frick C, et al: Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res 2007; 41:801–803
6.
Kopell BH, Greenberg B, Rezai AR: Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol 2004; 21:51–67
7.
Appleby BS, Duggan PS, Regenberg A, et al: Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years’ experience. Mov Disord 2007; 22:1722–1728
8.
Burkhard PR, Vingerhoets FJ, Berney A, et al: Suicide after successful deep brain stimulation for movement disorders. Neurology 2004; 63:2170–2172

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 468
PubMed: 19996258

History

Published online: 1 October 2009
Published in print: Fall, 2009

Authors

Details

Nahla A. Mahgoub, M.D.
Nabil Kotbi, M.D.
Department of Psychiatry, Weill Medical College of Cornell University, White Plains, NY

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share